Antigua and Barbuda vs Malta: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Antigua and Barbuda
- Malta
How they compare
Malta currently reports 37.73 deaths against 29.24 deaths in Antigua and Barbuda, a difference of 8.49 deaths.
That makes Malta's figure about 1.3 times Antigua and Barbuda's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Malta ahead.
Antigua and Barbuda ranks 142nd and Malta ranks 140th of 157 countries.
Across the 4 decades both report, Antigua and Barbuda averaged higher in 1 and Malta in 3.
Head to head by decade
| Decade | Antigua and Barbuda | Malta | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.02 deaths | 0 deaths | 2.02 deaths | Antigua and Barbuda |
| 2000s | 6.04 deaths | 7.82 deaths | 1.79 deaths | Malta |
| 2010s | 18.66 deaths | 21.94 deaths | 3.28 deaths | Malta |
| 2020s | 25.07 deaths | 34.89 deaths | 9.82 deaths | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Antigua and Barbuda or Malta?
- Malta, at 37.73 deaths against 29.24 deaths in Antigua and Barbuda as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Antigua and Barbuda and Malta?
- 8.49 deaths, with Malta ahead.
- How many years of comparable data are there for Antigua and Barbuda and Malta?
- 35 years are reported by both, from 1990 to 2024.
- How do Antigua and Barbuda and Malta rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Antigua and Barbuda ranks 142nd and Malta ranks 140th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.